Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management
- 21 January 2021
- journal article
- review article
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 37 (4), 547-559
- https://doi.org/10.1016/j.cjca.2021.01.016
Abstract
No abstract availableKeywords
Funding Information
- Canada Research Chairs (CRC-54205, GS-13561)
- Canadian Institutes of Health Research (CRC-54205, GS-13561)
- Heart and Stroke Foundation of Canada (CRC-54205, GS-13561)
This publication has 112 references indexed in Scilit:
- Genetic Cardiomyopathies Causing Heart FailureCirculation Research, 2013
- Dilated cardiomyopathy: the complexity of a diverse genetic architectureNature Reviews Cardiology, 2013
- Rescue of cardiomyopathy through U7snRNA‐mediated exon skipping in Mybpc3‐targeted knock‐in miceEMBO Molecular Medicine, 2013
- A Dutch Fanconi AnemiaFANCCFounder Mutation in Canadian Manitoba MennonitesAnemia, 2012
- Truncations of Titin Causing Dilated CardiomyopathyThe New England Journal of Medicine, 2012
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Heart Rhythm, 2011
- Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathyAmerican Heart Journal, 2008
- Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 GeneAmerican Journal of Human Genetics, 2008
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Mapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1The New England Journal of Medicine, 1989